GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Searle Co Ltd (KAR:SEARL) » Definitions » Cash Flow from Financing

The Searle Co (KAR:SEARL) Cash Flow from Financing : ₨-1,924 Mil (TTM As of Dec. 2024)


View and export this data going back to 1993. Start your Free Trial

What is The Searle Co Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2024, The Searle Co paid ₨0 Mil more to buy back shares than it received from issuing new shares. It spent ₨351 Mil paying down its debt. It paid ₨0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent ₨0 Mil paying cash dividends to shareholders. It received ₨0 Mil on other financial activities. In all, The Searle Co spent ₨351 Mil on financial activities for the three months ended in Dec. 2024.


The Searle Co Cash Flow from Financing Historical Data

The historical data trend for The Searle Co's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Searle Co Cash Flow from Financing Chart

The Searle Co Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -213.22 13,667.42 515.16 -1,956.76 2,116.57

The Searle Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 332.41 -478.90 -568.67 -524.96 -351.01

The Searle Co Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

The Searle Co's Cash from Financing for the fiscal year that ended in Jun. 2024 is calculated as:

The Searle Co's Cash from Financing for the quarter that ended in Dec. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨-1,924 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Searle Co  (KAR:SEARL) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

The Searle Co's issuance of stock for the three months ended in Dec. 2024 was ₨0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

The Searle Co's repurchase of stock for the three months ended in Dec. 2024 was ₨0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

The Searle Co's net issuance of debt for the three months ended in Dec. 2024 was ₨-351 Mil. The Searle Co spent ₨351 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

The Searle Co's net issuance of preferred for the three months ended in Dec. 2024 was ₨0 Mil. The Searle Co paid ₨0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

The Searle Co's cash flow for dividends for the three months ended in Dec. 2024 was ₨-0 Mil. The Searle Co spent ₨0 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

The Searle Co's other financing for the three months ended in Dec. 2024 was ₨0 Mil. The Searle Co received ₨0 Mil on other financial activities.


The Searle Co Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of The Searle Co's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


The Searle Co Business Description

Traded in Other Exchanges
N/A
Address
Tipu Sultan Road, Plot No. 1, One IBL Centre, 2nd Floor, Block 7 and 8, D.M.C.H.S, Off Shahra-e-Faisal, Karachi, SD, PAK, 75530
The Searle Co Ltd is a pharmaceutical company. It is principally engaged in the manufacture of pharmaceutical and other consumer products. The company manufactures pharmaceutical products like Hydryllin, Extor, Nuberol, Forte, Peditral, Selanz SR, Tramal, and other products. Its pharmaceutical product range covers the therapeutic areas of cardiovascular, antibiotics, nutrition, respiratory care, gastroenterology, oncology, hepatology, neurology and psychiatry, probiotics, antibiotics, and nutritional care.

The Searle Co Headlines

No Headlines